Relmada Therapeutics, Inc. RLMD

AC Immune Reaches Key Milestone in Alzheimer's Immunotherapy, Receives CHF 24.6M
Benzinga
·
10 mins ago
5mins
AC Immune (ACIU.US)
3.270
3.530
+2.83%
+7.95%

AC Immune SA (NASDAQ:ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced that it will receive the second ReTain-related milestone payment (CHF 24.6 million) under its agreement with Janssen Pharmaceuticals, Inc. (Janssen), a Johnson & Johnson company.

The milestone payment

Stock market is trash now days to many naked shorts look at short cap stocks the charts show all them going down to nothing it’s a fix with the mm’s

Short selling killed the markets

Mm’s are ruining the markets u can’t make any money anymore there all fucked up

Stock market is so fucked since last 3 years look at all small caps on the 3 month chart every one is getting dropped to nothing

Great finish wish stayed green but on a red day we did fine

Breakout in progress

Don’t let these shorts win guys

Big news incoming